BofA, Jefferies, SVB Securities, Evercore ISI and Guggenheim acted as joint book running managers for the offering.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on PCVX:
- Vaxcyte Announces Pricing of $500 Million Public Offering
- Vaxcyte initiated with an Outperform at TD Cowen
- Vaxcyte price target raised to $68 from $63 at BofA
- Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
- Vaxcyte announces offering of common stock, warrants